Get Started

NYMXF

PINK Nymox Pharmaceutical Corp
Oct 25, 2026 · 10:58 PM ET EOD Market Closed

$0.0600 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0600, and at the day’s high of $0.0600

YTD change
+49.25%
vs 20-day SMA
+46.02%
vs 200-day SMA
-9.83%

Price ranges

Previous day
$0.0400 $0.0600
open $0.0400 close $0.0600
+$0.0200 (+50.00%)
Today
$0.0400 $0.0600
$0.0600
Past week
$0.0320 $0.1419
from $0.0320 now $0.0600
+$0.0280 (+87.50%)
Past month
$0.0002 $0.1419
from $0.0002 now $0.0600
+$0.0598 (+29900.00%)
This year
$0.0002 $0.1999
from $0.0402 now $0.0600
+$0.0198 (+49.25%)

Price & Performance

+0.01 (+26.32%) / 6M

$-0.0118$0.0461$0.1041$0.1620Apr 27Jul 7Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 95.3% away from all-time highs of $1.2750
  • NYMXF is up 49% since the beginning of the year
  • NYMXF is down 46% over the past 12 months
  • NYMXF is up 29900% over the past 1 month
  • 0% of all NYMXF investors are betting against NYMXF

NYMXF reads neutral: price sits above one of the two key moving averages, the 12-month move is -43.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $10.9M
Beta -73.73

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$6.0K
Debt$5.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $6.3M

Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $805.02 -1.72%
IQV IQVIA Holdings Inc $279.36 +0.37%
CRL Charles River Laboratories International, Inc. $345.37 +1.68%
IT Gartner, Inc. $230.28 -1.77%
ICLR ICON Plc $185.27 -0.09%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.